All filters
Videos
Aramchol for NASH and beyond: From scientific rationale to clinical development | Carol Brosgart
Presented at:
HEP DART 2017
Videos
The Effectiveness of Treatment for Chronic Hepatitis C (and Hepatitis B) in Pediatric Populations | Manal El-Sayed, MD, PhD
Presented at:
HEP DART 2017
Videos
The Re-vival of Bile Acid Based Therapeutics for Children and Adults | Saul Karpen
Presented at:
HEP DART 2017
Videos
NASH Globally: Pathways to Combination Therapy, Biomarkers and Outcomes | Arun Sanyal
Presented at:
HEP DART 2017
Videos
Looking back to move forward: designing next-gen RNAi for best results in HBV | Bruce Given
Presented at:
HEP DART 2017
Videos
HEV Update: Diagnostics and Management | Kenneth Sherman, MD, PhD
Presented at:
HEP DART 2017
Videos
Revisiting the Molecular and Cell Biology of the Hepatitis B Virus Towards Elimination | Fabien Zoulim, MD, PhD
Presented at:
HEP DART 2017
Videos
Pan-genotypic direct-acting antiviral agents: Opportunity to achieve HCV elimination | Tarik Asselah
Presented at:
HEP DART 2017
Videos
DAA Controversies: Do they Cause HBV Reactivation and/or HCC? | Jordan Feld, MD, MPH
Presented at:
HEP DART 2017
Videos
SB 9200: A novel RIG-I agonist for chronic hepatitis B | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Presented at:
HEP DART 2017
Videos
Development of Immune Competent Small Animal Models for HBV | Helene Strick-Marchand
Presented at:
HEP DART 2017
Videos
Core Antibody: anti-HBc What is the Core of the Story? | Robert Gish, MD
Presented at:
HEP DART 2017
Videos
Endpoints and New Targets for Curing Hepatitis B | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Presented at:
HEP DART 2017
Videos
Is Host Genome Integrated HBV Relevant? - The Con Perspective | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Presented at:
HEP DART 2017
Videos
Short Duration DAA HCV Therapy: How Short Can We Go? | Shyam Kottilil, MD, PhD
Presented at:
HEP DART 2017
Videos
DAA Therapy and Reinfection Among People who Inject Drugs: Forming a Foundation for HCV Elimination | Jason Grebely
Presented at:
HEP DART 2017
Videos
Liver Disease in Chinese-perspective from a Hepatologist | George Lau, MBBS, MRCP, FHKCP, FHKAM, MD, FRCP
Presented at:
HEP DART 2017
Videos
Access to HIV, HBV, and HCV Antiviral Agents Globally | John Martin, PhD
Presented at:
HEP DART 2017